Market closedNon-fractional

Ardelyx/ARDX

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Ardelyx

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

Ticker

ARDX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Waltham, United States

Employees

267

Ardelyx Metrics

BasicAdvanced
$1.2B
Market cap
-
P/E ratio
-$0.29
EPS
0.82
Beta
-
Dividend rate
$1.2B
0.82
3.818
3.344
81.18
84.039
-5.66%
-13.83%
-47.64%
7.49
8.19
8.19
-14.7
152.32%
-21.61%
130.81%
-36.66%

What the Analysts think about Ardelyx

Analyst Ratings

Majority rating from 11 analysts.
Buy

Ardelyx Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-57.60% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$46M
34.11%
Net income
-$27M
-7.99%
Profit margin
-57.60%
-31.40%

Ardelyx Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 25.42%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.08
$0.03
-$0.12
-$0.11
-
Expected
-$0.11
-$0.11
-$0.09
-$0.15
-$0.11
Surprise
-30.17%
-128.07%
26.61%
-25.42%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Ardelyx stock?

Ardelyx (ARDX) has a market cap of $1.2B as of July 05, 2024.

What is the P/E ratio for Ardelyx stock?

The price to earnings (P/E) ratio for Ardelyx (ARDX) stock is 0 as of July 05, 2024.

Does Ardelyx stock pay dividends?

No, Ardelyx (ARDX) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Ardelyx dividend payment date?

Ardelyx (ARDX) stock does not pay dividends to its shareholders.

What is the beta indicator for Ardelyx?

Ardelyx (ARDX) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Ardelyx stock

Buy or sell Ardelyx stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing